Stock Price Quote

SYNGENE INTERNATIONAL LTD.

NSE : SYNGENEBSE : 539268ISIN CODE : INE398R01022Industry : Business SupportHouse : Private
BSE706.0522.8 (+3.34 %)
PREV CLOSE ( ) 683.25
OPEN PRICE ( ) 687.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 14195
TODAY'S LOW / HIGH ( )687.00 708.95
52 WK LOW / HIGH ( )608 960
NSE706.0523.25 (+3.41 %)
PREV CLOSE( ) 682.80
OPEN PRICE ( ) 685.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 706.05 (2)
VOLUME 583638
TODAY'S LOW / HIGH( ) 684.95 708.90
52 WK LOW / HIGH ( )607.65 960.6
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 18-11 1993
Management Info
Kiran Mazumdar - Shaw - Chairman - Managing Director
Registered Office

Address Biocon Sez, Biocon Park, No 2 & 3, Bommasandra,Industrail Area, Iv Pahse,Jigani Link Rd,
Bengaluru,
Karnataka-560099

Phone 080 6891 8000

Email investor@syngeneintl.com

Website www.syngeneintl.com

Registrars Details
K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE

NEWS

11Mar Syngene International’s arm acquires f
Syngene International’s wholly-owned subsidiary -- Syngene USA Inc. has..
11Mar Syngene International to make addition
Syngene International is all set to make an additional investment of upt..
11Mar Syngene International gains after arm
Syngene International is currently trading at Rs 680.00, up by 2.00 poin..
27Feb Syngene International informs about di
With reference to the intimation having reference no. Syn/CS/SE/Reg 30/2..
24Feb USFDA concludes pre-approval, cGMP ins
The United States Food and Drug Administration (USFDA) has conducted a p..

Financials

in Millions
QTR Dec 24 ANNUAL 24
Net Profit12314665
Gross Profit 1698 5573
Operating Profit 26889668
Net Sales 877132031

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Krystal Integrated (BSE)
peergroup  459.65 (7.22%)
M.Cap ( in Cr)642.22
Awfis Space Solution (BSE)
peergroup  606.55 (4.85%)
M.Cap ( in Cr)4304.26
EFC (I) (BSE)
peergroup  229.80 (10.61%)
M.Cap ( in Cr)2287.74
Just Dial (BSE)
peergroup  854.90 (2.14%)
M.Cap ( in Cr)7270.09
Latent View Analytic (BSE)
peergroup  372.20 (3.62%)
M.Cap ( in Cr)7684.87

Shareholding Pattern

NON-INSTITUTION 7.09%
PROMOTERS 52.74%
FI/BANKS/INSURANCE 3.24%
MUTUAL FUNDS/UTI 15.4%
GOVERNMENT 0%
FII 0%

About Syngene International Ltd.

Syngene International Ltd. was incorporated in the year 1993. Its today's share price is 706.05. Its current market capitalisation stands at Rs 28421.12 Cr. In the latest quarter, company has reported Gross Sales of Rs. 32069 Cr and Total Income of Rs.32911 Cr. The company's management includes Paul Frederick Blackburn, Sharmila Karve, Nilanjan Roy, Kush Parmar, Vinita Bali, Vijay Kuchroo, Catherine Rosenberg, Kiran Mazumdar - Shaw, Priyadarshini Mahapatra.

It is listed on the BSE with a BSE Code of 539268 , NSE with an NSE Symbol of SYNGENE and ISIN of INE398R01022. It's Registered office is at Biocon Sez, Biocon Park, No 2 & 3, Bommasandra,Industrail Area, Iv Pahse,Jigani Link RdBengaluru-560099, Karnataka. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are BSR & Co LLP, SR Batliboi & Associates, SR Batliboi & Associates LLP

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.